Notice of Correction to Eligibility of Foreign Components in PAR-14-200 "Clinical Trial Implementation Cooperative Agreement (U01)"

Notice Number: NOT-AR-15-004

Key Dates
Release Date: May 29, 2014

Related Announcements
 PAR-14-200

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to correct the following statements in PAR-14-200 "Clinical Trial Implementation Cooperative Agreement (U01)," which was published on May 1, 2014.

Part 2. Section III.1 Eligible Applicants

The language currently reads:

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

The language is modified to read:

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Inquiries

Please direct all inquiries to:

Shahnaz Khan
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-2463
Email: Khanshah@mail.nih.gov

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.